Daily FNArena News - Australia

Over the short term ResMed could find it difficult to surmount obstacles created by the pandemic while there is general agreement on an eventual return to growth

Is the worst of the pandemic behind Coles now, signalled by several features of shopping behaviour that are starting to normalise?

Ansell has been a beneficiary of the pandemic, causing another upgrade to earnings guidance. Is permanently higher demand for protective gloves a prospect?

Despite the structural pivot to clean energy, LNG is set for a multiyear recovery with Santos uniquely positioned to double production volumes by 2025

As BlueScope Steel revises guidance higher, once again, assessments of where peak earnings lie are becoming even more critical to the outlook

Record-breaking cold in the US state of Texas underpinned solid sales growth for Reliance Worldwide in the March quarter and management is confident momentum can be maintained

Does Kogan have an inventory problem? Rising costs and tougher comparables are expected to create a headache for the online retailer heading into FY22

Health insurance claims trends remain benign, suggesting nib Holdings will need to carefully manage expectations around a potential windfall from the pandemic

Consumption of product derived from mineral sands during the pandemic augurs well for Iluka Resources, although border closures deliver challenges

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments